1995-1998

1998 - Thymidylate synthase expression and activity : relation to S-phase parameters and 5-fluorouracil sensitivity

J.F. Mirjolet, M. Barberi-Heyob, J.L. Merlin, S. Marchal, M.C. Etienne,
G. Milano and P. Bey
Br J Cancer, 1998 Jul, 78(1): 62-8

EN SAVOIR PLUS
1998 - S9788 modulates P-gp and MRP mediated MDR in doxorubicin resistant MCF7cells

F. Bichat, M.A. Solis Recendez, M.G. Poullain, M.F. Poupon,
D. Khayat and G. Bastian
Biochem Pharmacol., 1998 Aug 15, 56(4): 497-502

EN SAVOIR PLUS
1998 - Multidrug resistance genes (MRP) and (MDR1) expression in small cell lung cancer xenografts : relationship with response to chemotherapy

Y. Canitrot, F. Bichat, S.P.C. Cole, R.G. Deeley, J.H. Gerlach, G. Bastian,
F. Arvelo and M.F. Poupon
Cancer Lett., 1998 Aug 14, 130(1-2): 133-41

EN SAVOIR PLUS
1997 - Two RNA-binding domains determine the RNA-binding specificity of nucleolin

G. Serin, G. Joseph, L. Ghisolfi, M. Bauzan, M. Erard, F. Amalric and P. Bouvet
Journal of Biological Chemistry, May 1997, 272(20): 13109-1

EN SAVOIR PLUS
1997 - French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours.

S. Chevillard, P. Vielh, P. Validire, J.P. Marie, A.M. Faussat, V. Barbu, C. Bayle, J. Benard, C. Bonnal, J. Boutonnat, F. Calvo, J. Charrier, A. Clary, P. Colosetti, L. Danel-Moore, P. Decremoux, C. Delvincourt, F. Finat-Duclos, P. Genne, A. Kataki, J.C. Kouyoumdjan, R. Lacave, C. Maugard, J.L. Merlin, M. Mousseau, F. Pinguet, V. Quillien, M. Raphael, B. Richard, P. Verrelle and J. Robert
Leukemia, 1997 Jul, 11(7): 1095-106

EN SAVOIR PLUS
1997 - Cytoskeleton alterations in MCF7R, a multidrug resistant human breast cancer cell line

F. Bichat, R. Mouawad, M.G. Solis Recendez, D. Khayat and G. Bastian
Anticancer Research, 1997 Sep-Oct, 17(5A): 3393-401

EN SAVOIR PLUS
1997 - Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy

E. Janevick Ivanovska, E. Gautherot, M. Hillairet de Boisferon, M. Cohen,
G. Milhaud, A. Tartar, W. Rostene, J. Barbet and A. Gruaz-Guyon
Bioconjug. Chem, 1997, 8(4): 526-533

EN SAVOIR PLUS
1997 - Pretargeted radioimmunotherapy using (131) I-labelled bivalent hapten-bearing peptides

M. Hillairet de Boisferon, C. Manetti, O. Raguin, E. Gautherot, W. Rostene,
J. Barbet and A. Gruaz-Guyon
Letters in Peptide Science, 1997, 4: 331-339

EN SAVOIR PLUS
1995 - Cinchonine administrated per os: efficient to circumvent P-glycoprotein mediated multidrug resistance in vivo

P. Genne, O. Duchamp, E. Solary, J. Magnette, J.P. Belon and B. Chauffert
Anticancer Drug Des, 1995 March, 10(2): 103-18

EN SAVOIR PLUS
1995 - Circumvention of confluence-dependent resistance in a human multidrug-resistant colon cancer cell line

C. Garrido, B. Chauffert, D. Pinard, F. Thibault, P. Genne,
M. Assem and M.T. Dimanche-Boitrel
International Journal of Cancer, 1995 Jun 9, 61(6): 873-9

EN SAVOIR PLUS
1995 - Cellular Pharmacology of azatoxins (Topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and negative cell lines

B. Eymin, E. Solary, S. Chevillard, L. Dubrez, F. Goldwasser, O. Duchamp,
P. Genne, F. Leteurtre and Y. Pommier
International of Cancer, 1995 Oct 9, 63(2): 268-75

EN SAVOIR PLUS
1995 - Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small-cell lung cancer xenografts

F. Arvelo, M.F. Poupon, F. Bichat, F. Grossin, Y. Bourgeois, M. Jacrot,
G. Bastian and T. Le Chevalier
European Journal of Cancer, 1995 Oct, 31A(11): 1862-8

EN SAVOIR PLUS